Yahoo to sell genetic home testing kits

Summary:Yahoo will soon begin selling home genetic testing kits for the general public to find out if they are susceptible to particular diseases.

Yahoo will soon begin selling home genetic testing kits for the general public to find out if they are susceptible to particular diseases.

The Japan Times reports that the tech giant will be involved in the marketing of a medical test kit to go on sale in Japan. According to Yahoo officials, the kit can be used to identify genetic markers that may make you more at risk of catching particular afflictions.

The kits are made by Tokyo-based Genesis Healthcare Co., and once the kit has been used, consumers have to send saliva samples to the firm, who will analyse the sample to see if the user is predisposed to afflictions including higher risks of stroke or gout. It takes two months for the results to arrive through an emailed URL.

In the face of making genetic kits available to consumers -- and the privacy risks associated with such products -- Yahoo Japan said:

"It is the No. 1 firm in Japan in the field that conducts analyses. A groundbreaking product good for preventive medicine will be made available at a low price."

The kits, priced at 29,800 yen ($371), are due to go on sale online in December. Yahoo Japan expects online sales to reach 300 units a month.

Image credit: Yahoo

Related:

This post was originally published on Smartplanet.com

Topics: Innovation

About

Charlie Osborne, a medical anthropologist who studied at the University of Kent, UK, is a journalist, freelance photographer and former teacher. She has spent years travelling and working across Europe and the Middle East as a teacher, and has been involved in the running of businesses ranging from media and events to B2B sales. Charli... Full Bio

zdnet_core.socialButton.googleLabel Contact Disclosure

Kick off your day with ZDNet's daily email newsletter. It's the freshest tech news and opinion, served hot. Get it.

Related Stories

The best of ZDNet, delivered

You have been successfully signed up. To sign up for more newsletters or to manage your account, visit the Newsletter Subscription Center.
Subscription failed.